You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anthracycline therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in São Paulo (Carvedilol, Placebo)

Recruiting
  • Cancer
  • São Paulo, Sao Paulo, Brazil
    Hospital Sirio Libanes
Sep 20, 2022

Cardiotoxicity, Childhood Cancer Trial in Montpellier (cardiac ultrasound with speckle tracking analysis)

Recruiting
  • Cardiotoxicity
  • Childhood Cancer
  • cardiac ultrasound with speckle tracking analysis
  • Montpellier, France
    Pediatric and Congenital Cardiology and Pulmonology Department,
Mar 23, 2023

Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)

Recruiting
  • Doxorubicin Induced Cardiomyopathy
  • Atorvastatin 40 Mg Oral Tablet
  • Placebo
  • Cairo, Egypt
    Ain Shams University hospitals
Apr 4, 2023

Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer

Active, not recruiting
  • Cancer
  • Cardiotoxicity
  • Exercise program
  • Hartford, Connecticut
  • +1 more
Jan 11, 2022

Defining Late Onset Occult Asymptomatic Cardiotoxicity in

Active, not recruiting
  • Cardiovascular Disease
  • Cardiac MRI
  • Hartford, Connecticut
    Connecticut Children's Medical Center
Jan 11, 2022

Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
Apr 1, 2022

Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

Completed
Has Results
  • Breast Neoplasms
  • Breast Cancer
  • Houston, Texas
  • +2 more
Jan 19, 2023

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

During Non-anthracycline Trastuzumab-based Therapy in Breast

Recruiting
  • Breast Cancer
  • Left Ventricular Ejection Fraction
  • Hartford, Connecticut
  • +7 more
Mar 7, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)

Withdrawn
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 19, 2021

Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

Recruiting
  • Luminal B/HER2-negative Breast Cancer
  • Dalpiciclib combined with aromatase inhibitors
  • anthracycline-cyclophosphamide followed by taxane
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022

Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant , Tropisetron and Olanzapine
  • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
  • Henan, Henan, China
  • +1 more
Apr 11, 2022

Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Recruiting
  • Breast Neoplasms
  • Taxanes or/and anthracycline-based therapy
  • Shengyang, Liaoning, China
  • +1 more
Jan 19, 2022

Triple Negative Breast Cancer Trial (biological, drug, radiation)

Withdrawn
  • Triple Negative Breast Cancer
  • avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

Completed
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Survey
  • Rochester, New York
    University of Rochester Medical Center
Mar 4, 2021

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction Trial in Lørenskog (Nicotinamide Riboside,

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Nicotinamide Riboside
  • Placebo
  • Lørenskog, Akershus, Norway
    Akershus University Hospital
Feb 14, 2023

Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • São Paulo, Brazil
    Instituto do Coração
Aug 16, 2023

HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)

Recruiting
  • HER-2 Positive Breast Cancer
  • TCbHP VS ddEC-THP
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
May 15, 2023

Lymphoma Trial in Rochester (Carvedilol, Lisinopril, Pravastatin)

Recruiting
  • Lymphoma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023